Literature DB >> 9390955

Growth hormone/IGF-I and/or resistive exercise maintains myonuclear number in hindlimb unweighted muscles.

D L Allen1, J K Linderman, R R Roy, R E Grindeland, V Mukku, V R Edgerton.   

Abstract

In the present study of rats, we examined the role, during 2 wk of hindlimb suspension, of growth hormone/insulin-like growth factor I (GH/IGF-I) administration and/or brief bouts of resistance exercise in ameliorating the loss of myonuclei in fibers of the soleus muscle that express type I myosin heavy chain. Hindlimb suspension resulted in a significant decrease in mean soleus wet weight that was attenuated either by exercise alone or by exercise plus GH/IGF-I treatment but was not attenuated by hormonal treatment alone. Both mean myonuclear number and mean fiber cross-sectional area (CSA) of fibers expressing type I myosin heavy chain decreased after 2 wk of suspension compared with control (134 vs. 162 myonuclei/mm and 917 vs. 2,076 micron2, respectively). Neither GH/IGF-I treatment nor exercise alone affected myonuclear number or fiber CSA, but the combination of exercise and growth-factor treatment attenuated the decrease in both variables. A significant correlation was found between mean myonuclear number and mean CSA across all groups. Thus GH/IGF-I administration and brief bouts of muscle loading had an interactive effect in attenuating the loss of myonuclei induced by chronic unloading.

Entities:  

Keywords:  NASA Center ARC; NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  1997        PMID: 9390955     DOI: 10.1152/jappl.1997.83.6.1857

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  24 in total

Review 1.  Apoptosis in skeletal muscle and its relevance to atrophy.

Authors:  Esther E Dupont-Versteegden
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

2.  In vivo time-lapse microscopy reveals no loss of murine myonuclei during weeks of muscle atrophy.

Authors:  Jo C Bruusgaard; Kristian Gundersen
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

Review 3.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

Review 4.  [Exercise and cellular adaptation of muscle].

Authors:  U Tegtbur; M W Busse; H P Kubis
Journal:  Unfallchirurg       Date:  2009-04       Impact factor: 1.000

Review 5.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.

Authors:  Kristian Gundersen
Journal:  Biol Rev Camb Philos Soc       Date:  2010-10-06

6.  Effects of functional electric stimulation cycle ergometry training on lower limb musculature in acute sci individuals.

Authors:  Timothy J Demchak; Jon K Linderman; W Jerry Mysiw; Rebecca Jackson; Jihong Suun; Steven T Devor
Journal:  J Sports Sci Med       Date:  2005-09-01       Impact factor: 2.988

7.  Sensitivity of rat soleus muscle to a mechanical stimulus is decreased following hindlimb unweighting.

Authors:  Kristina Csukly; Tanguy Marqueste; Phillip Gardiner
Journal:  Eur J Appl Physiol       Date:  2005-09-27       Impact factor: 3.078

Review 8.  Starring or Supporting Role? Satellite Cells and Skeletal Muscle Fiber Size Regulation.

Authors:  Kevin A Murach; Christopher S Fry; Tyler J Kirby; Janna R Jackson; Jonah D Lee; Sarah H White; Esther E Dupont-Versteegden; John J McCarthy; Charlotte A Peterson
Journal:  Physiology (Bethesda)       Date:  2018-01-01

Review 9.  Modulation of GH/IGF-1 axis: potential strategies to counteract sarcopenia in older adults.

Authors:  Silvia Giovannini; Emanuele Marzetti; Stephen E Borst; Christiaan Leeuwenburgh
Journal:  Mech Ageing Dev       Date:  2008-08-13       Impact factor: 5.432

Review 10.  Nuclear domains during muscle atrophy: nuclei lost or paradigm lost?

Authors:  Kristian Gundersen; Jo C Bruusgaard
Journal:  J Physiol       Date:  2008-04-25       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.